Published online Dec 7, 2025. doi: 10.3748/wjg.v31.i45.112926
Revised: September 3, 2025
Accepted: October 22, 2025
Published online: December 7, 2025
Processing time: 116 Days and 1.2 Hours
Perianal abscesses (PA) and pediatric fistula-in-ano (PFIA) are stages of the same perianal infectious disease, with PFIA often developing from PA. In children, PFIA predominantly affects male infants under one year, mostly involving low-level fistulas. The pathogenesis remains unclear, though infection and inflammation play central roles. Novel inflammatory markers, such as systemic inflammatory response index (SIRI), systemic immune-inflammation index (SII), neutro
To analyze changes in CBC and inflammatory markers in male infants and toddlers with PFIA.
Among 974 male infants and toddlers under six years of age, the case and control groups comprised 681 patients with PFIA and 293 healthy individuals, respec
PFIA was significantly associated with CBC-derived inflammatory markers. Compared with healthy controls, patients with PFIA demonstrated higher lymphocyte and lower MLR and SIRI levels, which remained robust after adjusting for patient age. Lymphocyte count, MLR, and SIRI had high predictive values. Additionally, lymphocyte count, MLR, and SIRI showed high clinical utility across a wide range of threshold probabilities, thus enhancing early detection and prognostic prediction. Finally, the number of fistula tracts in patients was significantly correlated with lymphocyte, MLR, and SIRI levels.
Lymphocyte count may be an inflammatory biomarker in the evaluation of PFIA among male infants and toddlers. Closer clinical observation and timely preventive or diagnostic measures will be beneficial.
Core Tip: This retrospective case-control study analyzed 974 male infants and toddlers, including 681 with pediatric fistula-in-ano (PFIA) and 293 healthy controls, to assess the relationship between complete blood count-derived inflammatory markers and PFIA. Patients showed higher lymphocyte counts but lower monocyte-to-lymphocyte ratio (MLR) and systemic inflammatory response index (SIRI) levels, which remained significant after age adjustment. Lymphocyte count, MLR, and SIRI demonstrated strong predictive value and clinical utility for PFIA detection and prognosis. The number of fistula tracts correlated with these markers. Lymphocyte count may serve as a useful biomarker, supporting early diagnosis and targeted prevention in pediatric PFIA.
